114 related articles for article (PubMed ID: 9331787)
1. Immunization with a single-repeat alpha C protein may prevent escape of lower repeat mutants of group B Streptococcus.
Gravekamp C; Kasper DL; Madoff LC
Adv Exp Med Biol; 1997; 418():855-7. PubMed ID: 9331787
[No Abstract] [Full Text] [Related]
2. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.
Gravekamp C; Rosner B; Madoff LC
Infect Immun; 1998 Sep; 66(9):4347-54. PubMed ID: 9712787
[TBL] [Abstract][Full Text] [Related]
3. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein.
Madoff LC; Michel JL; Gong EW; Kling DE; Kasper DL
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4131-6. PubMed ID: 8633028
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with highly purified cell surface proteins confers protection against experimental group B streptococcal infection.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Adv Exp Med Biol; 1997; 418():851-3. PubMed ID: 9331786
[No Abstract] [Full Text] [Related]
5. Development of experimental GBS vaccine for mucosal immunization.
Gupalova T; Leontieva G; Kramskaya T; Grabovskaya K; Bormotova E; Korjevski D; Suvorov A
PLoS One; 2018; 13(5):e0196564. PubMed ID: 29727446
[TBL] [Abstract][Full Text] [Related]
6. Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes.
Gravekamp C; Horensky DS; Michel JL; Madoff LC
Infect Immun; 1996 Sep; 64(9):3576-83. PubMed ID: 8751902
[TBL] [Abstract][Full Text] [Related]
7. Identification of a universal Group B streptococcus vaccine by multiple genome screen.
Maione D; Margarit I; Rinaudo CD; Masignani V; Mora M; Scarselli M; Tettelin H; Brettoni C; Iacobini ET; Rosini R; D'Agostino N; Miorin L; Buccato S; Mariani M; Galli G; Nogarotto R; Nardi-Dei V; Vegni F; Fraser C; Mancuso G; Teti G; Madoff LC; Paoletti LC; Rappuoli R; Kasper DL; Telford JL; Grandi G
Science; 2005 Jul; 309(5731):148-50. PubMed ID: 15994562
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
[TBL] [Abstract][Full Text] [Related]
9. Upstream short sequence repeats regulate expression of the alpha C protein of group B Streptococcus.
Puopolo KM; Madoff LC
Mol Microbiol; 2003 Nov; 50(3):977-91. PubMed ID: 14617155
[TBL] [Abstract][Full Text] [Related]
10. The Rib and alpha proteins define a family of group B streptococcal surface proteins that confer protective immunity.
Wästfelt M; Stålhammar-Carlemalm M; Delisse AM; Cabezon T; Lindahl G
Adv Exp Med Biol; 1997; 418():619-22. PubMed ID: 9331728
[No Abstract] [Full Text] [Related]
11. Tandem repeat deletion in the alpha C protein of group B streptococcus is recA independent.
Puopolo KM; Hollingshead SK; Carey VJ; Madoff LC
Infect Immun; 2001 Aug; 69(8):5037-45. PubMed ID: 11447184
[TBL] [Abstract][Full Text] [Related]
12. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.
Meinke AL; Senn BM; Visram Z; Henics TZ; Minh DB; Schüler W; Neubauer C; Gelbmann D; Noiges B; Sinzinger J; Hanner M; Dewasthaly S; Lundberg U; Hordnes K; Masoud H; Sevelda P; von Gabain A; Nagy E
Vaccine; 2010 Oct; 28(43):6997-7008. PubMed ID: 20732466
[TBL] [Abstract][Full Text] [Related]
13. Surface Structures of Group B
Paoletti LC; Kasper DL
Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30873933
[TBL] [Abstract][Full Text] [Related]
14. [Protective properties of certain external proteins of group B streptococci].
Grabovskaia KB; Leont'eva GF; Meringova LF; Vorob'eva EI; Suvorov AN; Totolian A
Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):44-50. PubMed ID: 18038546
[TBL] [Abstract][Full Text] [Related]
15. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Infect Immun; 1996 Sep; 64(9):3518-23. PubMed ID: 8751893
[TBL] [Abstract][Full Text] [Related]
16. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Vaccine; 1999 Feb; 17(5):454-8. PubMed ID: 10073723
[TBL] [Abstract][Full Text] [Related]
17. Genome analysis reveals pili in Group B Streptococcus.
Lauer P; Rinaudo CD; Soriani M; Margarit I; Maione D; Rosini R; Taddei AR; Mora M; Rappuoli R; Grandi G; Telford JL
Science; 2005 Jul; 309(5731):105. PubMed ID: 15994549
[TBL] [Abstract][Full Text] [Related]
18. Group B Streptococcus: global incidence and vaccine development.
Johri AK; Paoletti LC; Glaser P; Dua M; Sharma PK; Grandi G; Rappuoli R
Nat Rev Microbiol; 2006 Dec; 4(12):932-42. PubMed ID: 17088932
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus.
Li J; Kasper DL; Ausubel FM; Rosner B; Michel JL
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13251-6. PubMed ID: 9371832
[TBL] [Abstract][Full Text] [Related]
20. Group A and group B streptococcal vaccine development. A round table presentation.
Dale JB; Cleary PP; Fischetti VA; Kasper DL; Musser JM; Zabriskie JB
Adv Exp Med Biol; 1997; 418():863-8. PubMed ID: 9331789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
